Mount Sinai Establishes Eye and Vision Research Institute to Pursue Clinical Research

By Staff
Wednesday, January 18, 2017 12:18 AM NEW YORK—The Mount Sinai Health System earlier this week announced plans to develop the Mount Sinai/New York Eye and Ear (NYEE) Eye and Vision Research Institute, a facility that the health system said would be “the first of its kind in the New York City metropolitan region.”

ForSight VISION4, Inc. Announces Acquisition by Roche

By Staff
Monday, January 16, 2017 12:24 AM MENLO PARK, Calif.—ForSight VISION4 announced that it has been acquired by Roche Holdings Inc.

Novartis to Acquire Encore Vision, Developer of Eye Drop for Treating Presbyopia

By Staff
Wednesday, December 21, 2016 12:33 AM BASEL, Switzerland—Novartis announced yesterday that it has entered into a definitive agreement to acquire Encore Vision, a privately-held company in Fort Worth, Texas, that has developed eye drops for treating presbyopia.

Microsoft India, L V Prasad Eye Institute Launch Global Consortium to Tap Artificial Intelligence’s Power for Eyecare

By Staff
Wednesday, December 21, 2016 12:30 AM HYDERABAD, India—Microsoft India and the L V Prasad Eye Institute have teamed up to launch the Microsoft Intelligent Network for Eyecare (MINE), which they describe as “a global consortium of commercial, research and academic institutions who have joined to apply artificial intelligence to help in the elimination of avoidable blindness and scale delivery of eyecare services worldwide.”

Sun Pharma Completes Acquisition of Ocular Technologies Sarl

By Staff
Wednesday, December 21, 2016 12:15 AM NEW DELHI—Sun Pharmaceutical Industries announced that it has completed the acquisition of U.S.-based eyecare specialist Ocular Technologies Sarl, a portfolio company of Auven Therapeutics.

OWL: Advancing Diversity in Leadership Adds Four Members to Its Board of Directors

By Staff
Monday, November 28, 2016 12:21 AM KANSAS CITY, Mo.—OWL: Advancing Diversity in Leadership announced that Michael Ackermann, PhD, Taryn Conway, Candace Simerson, and John Vukich, MD, have joined OWL’s board of directors.

Alcon Says Research on Smart Contact Lenses Is ‘Progressing Steadily’

By Staff
Monday, November 21, 2016 12:24 AM FORT WORTH, Texas—Despite news reports that Alcon’s smart contact lens research project with Alphabet Inc.’s Verily unit is behind schedule, the company maintains that it is in fact on track, VMail has learned.

Allergan Founder Gavin Herbert and Wife, Ninetta Herbert, Pledge $5 Million to UC Irvine for Retinal Research

By Staff
Monday, November 21, 2016 12:18 AM IRVINE, Calif.—Allergan founder Gavin Herbert and his wife, Ninetta, have pledged $5 million to advance retinal research at UC Irvine Health’s Gavin Herbert Eye Institute, the academic eyecare center named in his honor.

Valeant’s Revenue Drops 11 Percent in Third Quarter 2016

By Staff
Friday, November 11, 2016 12:26 AM LAVAL, Quebec—Valeant Pharmaceuticals International (NYSE: VRX) reported that its total revenues in the third quarter ended September 30, 2016 were $2.48 billion versus $2.79 billion in the third quarter of 2015, a decrease of 11 percent.

Ophthotech Reports Losses for Third Quarter and Year-to-Date

By Staff
Wednesday, November 9, 2016 12:23 AM NEW YORK—Ophthotech Corp. (Nasdaq: OPHT) reported a net loss for the quarter ended September 30, 2016 of $60.9 million compared to a net loss of $39.6 million for the same period in 2015.

STAAR Surgical’s 3Q Net Sales Up 7 Percent

By Staff
Monday, November 7, 2016 12:23 AM MONROVIA, Calif.—STAAR Surgical Company (NASDAQ: STAA), reported net sales of $20.1 million for the third quarter ended Sept. 30, 2016, up 7 percent compared to $18.8 million reported in the prior year quarter.

Keck School of Medicine of USC Interim Dean to Discuss Telemedicine at U.S. News & World Report Conference

By Staff
Monday, November 7, 2016 12:21 AM WASHINGTON—The fourth annual U.S. News & World Report Leadership Forum, "Healthcare of Tomorrow," features national thought leaders, including Rohit Varma, MD, MPH, interim dean of the Keck School of Medicine of USC and president of USC Care physician medical group, speaking on a range of topics that will shape the future of America's health care system.

Allergan Reports Q3 2016 Continuing Operations Performance with GAAP Net Revenues of $3.6 Billion

By Staff
Friday, November 4, 2016 12:23 AM DUBLIN—Allergan plc (NYSE: AGN) reported total net revenue of $3.6 billion for the third quarter ending Sept. 30, 2016, a 4 percent increase versus the prior year quarter.

Second Sight Posts Losses for 3Q and Year to Date

By Staff
Friday, November 4, 2016 12:22 AM SYLMAR, Calif—Second Sight Medical Products (NASDAQ:EYES), maker of the Argus II Retinal Prosthesis Systems, reported losses for the three- and nine-month periods ended Sept. 30, 2016.

Second Sight Implants and Activates Wireless Visual Cortical Stimulator in First Human Subject

By Staff
Friday, October 28, 2016 12:30 AM SYLMAR, Calif.—Second Sight Medical Products announced the first successful implantation and activation of a wireless visual cortical stimulator in a human.
Loading...